The Europe OTC drug and dietary supplement market was valued at US$ 85,835.9 million in 2019 and is projected to reach US$ 141,676.3 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
The growth of the OTC drug and dietary supplement market in Europe is mainly attributed to the factors such as rising general health issues, and preference of OTC drugs. However, stringent government regulation for OTC drugs is the major factor hindering the market growth.
Over the counter (OTC) drugs are available for the public for their general use.These drugs do not require a prescription from a physician.
OTC medicines are available for various medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, and pain.On the other hand, dietary supplements are available over the counter for fitness purposes.
Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients require a prescription from a physician. These OTC drugs and dietary supplements are of two types: branded and generic.
People nowadays are aware of general health issues such as cold, cough, allergies, fever, pain, acidity, diarrhea, and skin-related conditions.Moreover, people are focused on having healthy lifestyle and avoiding the consumption of junk food that leads to lifestyle-related diseases such as diabetes, obesity, and cardiovascular diseases.
Growing preference toward maintaining the healthy lifestyle also leads to the consumption of weight-loss products and dietary supplements, including vitamins, minerals, and supplements. Increasing exposure to internet has resulted in easy access to dietary supplements and over the counter (OTC) drugs to consumers, at affordable prices.
Government and consumers’ mounting pressure on reducing price would help accelerate the prescription to OTC (Rx-to-OTC) transition.There is widespread support for OTC usage among physicians for fever, cold/cough, and other minor ailments; beyond that, the physicians do have some reservations.
Although there are generic prescription medications that are cheaper than OTC drugs, most of the OTC drugs are cheaper than prescription drugs.
As the number of COVID-19 cases is increasing in the European countries, the purchase of dietary supplement and vitamins has been significantly increased. People are buying these products to increase immunity and combat the spread of COVID-19.
Based on product, the OTC drug and dietary supplement market is segmented into analgesics, cough and cold products, vitamins and dietary supplements, gastrointestinal products, antacids, ophthalmic products, sleep aids, oral care products, feminine care, and others. The analgesics segment held the largest share of the market in 2019; however, the market for vitamins and dietary supplements is estimated grow at the highest CAGR in the market during the forecast period. Based on type, the market is segmented into generic and branded.Based on form, the market is segmented into tablets, capsules, powders, liquid, ointments, and others.
Based on distribution channel, the market is segmented into hospital and retail pharmacies, retail stores, online channels, and others.
The World Health Organization (WHO), European Pharmacy Network, National Center for Biotechnology Information, along with company websites are among the major primary and secondary sources referred for preparing this report.
Our reports have been used by over 10K customers, including:
121 pages •
By Euromonitor International
• Nov 2020
The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded...
The North America OTC drug and dietary supplement market was valued at US$ 131,818.3 million in 2019 and is projected to reach US$ 224,349.5 million by 2027; it is expected to grow at a CAGR of 7.0% during 2020–2027. The growth of the OTC drug and dietary supplement market is mainly attributed to the factors such as rising awareness...
Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2020 Summary Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes....
The global migraine drugs market grew at a CAGR of around 14% during 2014-2019. Migraine is a neurological condition that causes unilateral or throbbing pain in the forehead, side of the head or around the eyes. The pain is often accompanied by autonomic symptoms, such as nausea, vomiting, photophobia and phonophobia....
111 pages •
By Euromonitor International
• Nov 2020
Overall, the COVID-19 pandemic has had a significant negative impact on consumer health sales in China in 2020, as a result of lockdown restrictions on retailing and public movement, and the disruption of logistics and retail operations. Consumer Health in China report offers a comprehensive guide to the size and shape of the market...
The OTC drug and dietary supplement market was valued at US$ 2, 93,255.40 million in 2019 and is projected to reach US$ 4, 92,102.49 million by 2027; it is expected to grow at a CAGR of 6.8% from 2020 to 2027. The growth of the OTC drug and dietary supplements marketis mainly attributed to the factors such as growing awareness regarding...
Bio-succinic Acid Market report 2020 presents a strategic analysis of the global Bio-succinic Acid market over the forecast period from 2020 to 2026. The report presents a unique perspective on the future landscape of how COVID-19 transformed Bio-succinic Acid growth prospects. The overall economic recovery will be the main indicator of the...
Vitamin B-complex Ingredients Market report 2020 presents a strategic analysis of the global Vitamin B-complex Ingredients market over the forecast period from 2020 to 2026. The report presents a unique perspective on the future landscape of how COVID-19 transformed Vitamin B-complex Ingredients growth prospects. The overall economic recovery...
The global gummy vitamins market size is estimated to be valued at USD 5.9 billion in 2020 and projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5%, in terms of value. Factors such as the rising incidences of vitamin deficiencies and undernourishments, along with growing awareness for on-the-go supplements, offering pleasant...
117 pages •
By Euromonitor International
• Oct 2020
COVID-19 has brought significant changes to consumer health in the US as consumer priorities and routines have shifted more towards preventive health and wellness. While the first two months of 2020 saw minimal changes in behaviour, the sudden shift in attention towards the virus in early March led to rapid stockpiling behaviour of multiple...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.